CUMYL-4CN-BINACA
CUMYL-4CN-BINACA[edit]
CUMYL-4CN-BINACA is a synthetic cannabinoid that has been used as a designer drug. It is a potent agonist of the cannabinoid receptors, which are part of the endocannabinoid system in the human body. This compound is part of a class of synthetic cannabinoids that are often found in products marketed as "legal highs" or "herbal incense."
Chemical Structure and Properties[edit]
CUMYL-4CN-BINACA is chemically classified as an indazole-based synthetic cannabinoid. Its structure includes a cyano group attached to the phenyl ring, which is believed to contribute to its high potency. The compound is designed to mimic the effects of tetrahydrocannabinol (THC), the primary psychoactive component of cannabis.
Pharmacology[edit]
As a synthetic cannabinoid, CUMYL-4CN-BINACA acts on the CB1 receptor and CB2 receptor, which are G protein-coupled receptors in the central nervous system and peripheral nervous system. The activation of these receptors by CUMYL-4CN-BINACA can lead to a range of effects, including altered perception, mood changes, and impaired motor function.
Legal Status[edit]
Due to its potential for abuse and lack of medical use, CUMYL-4CN-BINACA is classified as a controlled substance in many countries. The legal status of synthetic cannabinoids can vary widely, with some jurisdictions implementing specific bans on these compounds.
Health Effects and Risks[edit]
The use of CUMYL-4CN-BINACA has been associated with adverse health effects, including tachycardia, hypertension, nausea, and vomiting. In severe cases, it can lead to psychosis, seizures, and even death. The variability in potency and the presence of unknown adulterants in products containing synthetic cannabinoids increase the risk of harmful effects.
Related Compounds[edit]
CUMYL-4CN-BINACA is related to other synthetic cannabinoids such as AB-FUBINACA, ADB-PINACA, and 5F-ADB. These compounds share similar mechanisms of action and are often found in similar products.
See Also[edit]
Related Pages[edit]
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa
Tired of being overweight?
Special offer:
Budget GLP-1 weight loss medications
- Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
- Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay
✔ Same-week appointments, evenings & weekends
Learn more:
- GLP-1 weight loss clinic NYC
- W8MD's NYC medical weight loss
- W8MD Philadelphia GLP-1 shots
- Philadelphia GLP-1 injections
- Affordable GLP-1 shots NYC
- Budget GLP-1 shots
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
